Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot study

Am J Hematol. 2020 Oct;95(10):E272-E276. doi: 10.1002/ajh.25919. Epub 2020 Jul 27.

Authors

Terrence H Diamond¹, Terry Golombick¹, Arumugam Manoharan², Rajeev Ramakrishna², Carl Bryant³

Affiliations

¹ Department of Endocrinology, St George Hospital, Sydney, New South Wales, Australia.
² Southern Sydney Haematology, University of Wollongong, Wollongong, New South Wales, Australia.
³ Bryant Radiology, Kogarah, Sydney, New South Wales, Australia.

PMID: 32602126
DOI: 10.1002/ajh.25919

No abstract available

Publication types

Letter